MURRYSVILLE, Pa., Feb. 19, 2014 /PRNewswire/ -- Respironics, Inc., a Philips Healthcare business, today announced a worldwide recall of approximately 600 Philips Respironics Trilogy Ventilators, ...

– Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

One of the nation's largest makers of machines for sleep apnea sufferers has agreed to pay $479 million to compensate customers who bought the devices and suffered injuries due to foam spewing into ...

Please provide your email address to receive an email when new articles are posted on . The FDA designated the recall of Philips Respironics DreamStation devices as class I. The devices are used in ...

Amsterdam, the Netherlands - Following the FDA’s inspection of Philips Respironics’ facility in Murrysville in 2021 and the subsequent inspectional observations, the US Department of Justice (DOJ), ...

Koninklijke Philips N.V. stock was upgraded from sell to hold in April 2023, jumping 28% due to a settlement regarding apnea devices. Despite a €982 million settlement provision for Respironics, ...

The same investigative journalists who took Philips to task last year for waiting 11 years before coming forward with its respiratory device problem, recently revealed new insights into the saga. The ...

Please provide your email address to receive an email when new articles are posted on . After agreeing to the proposed FDA consent decree in January, Philips Respironics has agreed to the finalized ...

Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal in the United States to settle lawsuits over faulty sleep machines in a case that have dogged the company. The company ...

Amsterdam, The Netherlands - Royal Philips Electronics (NYSE: PHG, AEX:PHI) (“Philips”) today announced the completion of the tender offer by its wholly owned subsidiary, Moonlight Merger Sub, Inc.

1) Excluding provisions charged to sales of EUR 174 million in Q4 2023 mainly in connection with the Respironics consent decree. Roy Jakobs, CEO of Royal Philips:“Our strong results in 2023 were ...